Prognostic impact of conventional cytogenetics in acute myeloid leukemia treated with venetoclax and decitabine. Venugopal S, Maiti A, DiNardo CD, Qiao W, et al. Leuk Lymphoma 2021 Sep 3:1-5. doi: 10.1080/10428194.2021.1973675.

Read + Share

Amedeo Smart

Independent Medical Education

Venugopal S, Maiti A, DiNardo CD, Qiao W, et al. Prognostic impact of conventional cytogenetics in acute myeloid leukemia treated with venetoclax and decitabine. Leuk Lymphoma 2021 Sep 3:1-5. doi: 10.1080/10428194.2021.1973675.
PMID: 34474640